Murrieta (PRWEB) April 21, 2021 Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that simplSEQ, an incubator company, has
Dr. John C. Spinosa Joins Murrieta Genomics as Chief Medical Officer
Share Article
Addition of noted pathologist to executive team provides insights into precision medicine and critical connections to the greater life science community.
Dr. John C. Spinosa MURRIETA, Calif. (PRWEB) February 02, 2021
Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that John C. Spinosa, M.D., Ph.D., has joined the executive management team. He has also been appointed as Chief Medical Officer of SimplSEQ, Inc., a wholly owned subsidiary of Murrieta Genomics.
“We are fortunate to have attracted Dr. Spinosa to join us,” stated Jay Goth, CEO. “John’s background and experience with companies large and small will be critical to our future success helping genomic sequencing companies revolutionize the healthcare, agriculture and forensic industries. His reputation as a leading pathologist is well